<!DOCTYPE html>
<html lang="en" dir="ltr">
    <head>
        <meta charset="utf-8">
        <link rel="stylesheet" href="uslm.css">
        <link rel="stylesheet" href="style.css">
        <script lang="text/javascript" src="omni.js" defer></script>
        <title> Omnibuster Section </title>
    </head>

    <body>
        <div class="section">
            <h1> Section s3202 </h1>
            <div class="buttons">
                <div>
                    <button onclick="highlightSelection();">Highlight Text</button>
                </div>
                <div>
                    <button onclick="annotateSelection();">[Not working] Annotate Text</button>
                </div>
            </div>
            <p> <section id="d3355e14066" identifier="/us/bill/116/hr/748/dA/tIII/stA/ptII/sptA/s3202" style="-uslm-lc:I650144"><num value="3202">SEC. 3202. </num><heading>PRICING OF DIAGNOSTIC TESTING.</heading><subsection class="indent0 fontsize10" id="d3355e14071" identifier="/us/bill/116/hr/748/dA/tIII/stA/ptII/sptA/s3202/a" style="-uslm-lc:I650120"><num style="-uslm-lc:emspace2" value="a">(a) </num><heading><inline class="small-caps">Reimbursement Rates</inline>.—</heading><chapeau>A group health plan or a health insurance issuer providing coverage of items and services described in section 6001(a) of division F of the Families First Coronavirus Response Act (<ref href="/us/pl/116/127">Public Law 116–127</ref>) with respect to an enrollee shall reimburse the provider of the diagnostic testing as follows:</chapeau><paragraph class="indent1 fontsize10" id="d3355e14083" identifier="/us/bill/116/hr/748/dA/tIII/stA/ptII/sptA/s3202/a/1" style="-uslm-lc:I650122"><num style="-uslm-lc:emspace2" value="1">(1) </num><content>If the health plan or issuer has a negotiated rate with such provider in effect before the public health emergency declared under section 319 of the Public Health Service Act (<a href="https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title42-section247d&amp;num=0&amp;edition=prelim"><ref href="/us/usc/t42/s247d">42 U.S.C. 247d</ref></a>), such negotiated rate shall apply throughout the period of such declaration.</content>
</paragraph>
<paragraph class="indent1 fontsize10" id="d3355e14093" identifier="/us/bill/116/hr/748/dA/tIII/stA/ptII/sptA/s3202/a/2" style="-uslm-lc:I650122"><num style="-uslm-lc:emspace2" value="2">(2) </num><content>If the health plan or issuer does not have a negotiated rate with such provider, such plan or issuer shall reimburse the provider in an amount that equals the cash price for such service as listed by the provider on a public internet website, or such plan or issuer may negotiate a rate with such provider for less than such cash price.</content>
</paragraph>
</subsection>
<subsection class="indent0 fontsize10" id="d3355e14101" identifier="/us/bill/116/hr/748/dA/tIII/stA/ptII/sptA/s3202/b" style="-uslm-lc:I650120"><num style="-uslm-lc:emspace2" value="b">(b) </num><heading><inline class="small-caps">Requirement to Publicize Cash Price for Diagnostic Testing for COVID–19</inline>.—</heading><paragraph class="indent1 fontsize10" id="d3355e14108" identifier="/us/bill/116/hr/748/dA/tIII/stA/ptII/sptA/s3202/b/1" style="-uslm-lc:I650122"><num style="-uslm-lc:emspace2" value="1">(1) </num><heading><inline class="small-caps">In general</inline>.—</heading><content>During the emergency period declared under section 319 of the Public Health Service Act (<a href="https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title42-section247d&amp;num=0&amp;edition=prelim"><ref href="/us/usc/t42/s247d">42 U.S.C. 247d</ref></a>), each provider of a diagnostic test for COVID–19 shall make public the cash price for such test on a public internet website of such provider.</content>
</paragraph>
<paragraph class="indent1 fontsize10" id="d3355e14122" identifier="/us/bill/116/hr/748/dA/tIII/stA/ptII/sptA/s3202/b/2" style="-uslm-lc:I650122"><num style="-uslm-lc:emspace2" value="2">(2) </num><heading><inline class="small-caps">Civil monetary penalties</inline>.—</heading><content>The Secretary of Health and Human Services may impose a civil monetary penalty on any provider of a diagnostic test for COVID–19 that is not in compliance with paragraph (1) and has not completed a corrective action plan to comply with the requirements of such paragraph, in an amount not to exceed $300 per day that the violation is ongoing.</content>
</paragraph>
</subsection>
</section>
            </p>
        </div>  
    </body>